product summary
Loading...
company name :
Novus Biologicals
other brands :
IMGENEX
product type :
antibody
product name :
ZMPSTE24 Antibody - BSA Free
catalog :
NB100-2388
quantity :
0.1 ml
price :
409 USD
clonality :
polyclonal
host :
domestic rabbit
conjugate :
nonconjugated
reactivity :
human, mouse
application :
western blot
more info or order :
citations: 1
product information
brand :
Novus
catalog number base :
NB100-2388
SKU :
NB100-2388
product name :
ZMPSTE24 Antibody - BSA Free
units size :
0.1 ml
description :
The ZMPSTE24 Antibody - BSA Free from Novus is a rabbit polyclonal antibody to ZMPSTE24. This antibody reacts with human,mouse. The ZMPSTE24 Antibody - BSA Free has been validated for the following applications: Western Blot.
target :
ZMPSTE24
category :
Primary Antibodies
buffer :
PBS
clonality :
Polyclonal
concentration :
1.0 mg/ml
conjugate :
Unconjugated
all_available conjugate :
Unconjugated
host :
Rabbit
immunogen :
A synthetic peptide made to a C-terminal portion of the human ZMPSTE24 protein sequence (between residues 400-475). [Swiss-Prot# O75844]
isotype :
IgG
purity :
Immunogen affinity purified
species :
Human,Mouse
theoretical molecular weight :
54 kDa
gene symbol :
ZMPSTE24
top caption :
Western Blot: ZMPSTE24 Antibody [NB100-2388]
applications :
Western Blot
USD :
409 USD
alt names :
zona pellucida binding protein 2, zona pellucida-binding protein 2, ZPBP-like protein, ZPBPLMGC41930
storage :
Aliquot and store at -20C or -80C. Avoid freeze-thaw cycles.
more info or order :
company information

Novus Biologicals
10771 E Easter Ave
Centennial, CO 80112
Centennial, CO 80112
novus@novusbio.com
https://www.novusbio.com3037301950
headquarters: USA
Novus Biologicals licenses, manufactures, and markets antibodies to over 20,000 unique targets to support a wide array of research areas. Novus is built on honesty, collaboration and strong relationships and continues to provide quality tools that accelerate research. Every product is backed by our 100% guarantee.
browse more products
questions and comments
